$0
$773,000
0.0% of portfolio
9,762
Q2 2025
Reduced 38.64%
$0
$440,000
0.0% of portfolio
6,463
Q2 2025
Reduced 14.54%
$0
$623,000
0.0% of portfolio
12,083
Q2 2025
Reduced 3.2%
$325M
$1.1 Million
0.0% of portfolio
147,199
Q2 2025
Added 196.97%
$2.35B
$1.37 Million
0.0% of portfolio
142,405
Q2 2025
Added 243.13%
$11.9B
$300,000
0.0% of portfolio
8,323
Q2 2025
Reduced 92.65%
$59.7B
$3.52 Million
0.0% of portfolio
41,102
Q2 2025
Reduced 84.44%
$1.6B
$4.9 Million
0.0% of portfolio
133,644
Q2 2025
Added 78.21%
$95.3B
$851,000
0.0% of portfolio
3,851
Q2 2025
Reduced 95.8%
$157M
$2.12 Million
0.0% of portfolio
541,613
Q2 2025
Reduced 29.51%
$1.05B
$2.99 Million
0.0% of portfolio
55,957
Q2 2025
Added 17.35%
-
$0
0.0% of portfolio
-
Q2 2025
New
$25.8B
$2.25 Million
0.0% of portfolio
16,178
Q2 2025
Reduced 26.41%
$291M
$2 Million
0.0% of portfolio
35,713
Q2 2025
Reduced 0.72%
$4.86B
$4.49 Million
0.0% of portfolio
69,470
Q2 2025
Reduced 38.63%
$845M
$1.88 Million
0.0% of portfolio
42,894
Q2 2025
Added 321.98%
-
$0
0.0% of portfolio
-
Q2 2025
Added 1,102.98%
$0
$1.2 Million
0.0% of portfolio
21,038
Q2 2025
Added 168.41%
$744M
$143,000
0.0% of portfolio
11,555
Q2 2025
Reduced 49.39%
-
$0
0.0% of portfolio
-
Q4 2024
New
$481M
$971,000
0.0% of portfolio
151,502
Q2 2025
Reduced 43.89%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 13.35%
Andretti Acquisition Corp Ii
-
$0
0.0% of portfolio
-
Q1 2025
Added 15.0%
$229M
$325,000
0.0% of portfolio
34,592
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 1,050.39%
$346M
$648,000
0.0% of portfolio
65,342
Q2 2025
Reduced 71.7%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 69.51%
$1.54B
$4.46 Million
0.0% of portfolio
68,292
Q2 2025
Reduced 70.27%
$127M
$1.31 Million
0.0% of portfolio
124,079
Q2 2025
Reduced 26.04%
Annaly Capital Management In
-
$0
0.0% of portfolio
-
Q2 2025
Added 36.91%
$424M
$5.96 Million
0.0% of portfolio
232,388
Q2 2025
Reduced 6.45%
$1.16B
$3.69 Million
0.0% of portfolio
426,736
Q2 2025
Reduced 42.57%
$2.63B
$4.35 Million
0.0% of portfolio
251,069
Q2 2025
New
Apellis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2023
New
$961M
$6.09 Million
0.0% of portfolio
149,967
Q2 2025
Added 42.65%
-
$0
0.0% of portfolio
-
Q2 2025
Added 2,116.59%
$1.41B
$2.1 Million
0.0% of portfolio
216,670
Q2 2025
Added 895.63%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 61.34%
-
$0
0.0% of portfolio
-
Q1 2023
New
$5.5B
$3.17 Million
0.0% of portfolio
13,747
Q2 2025
Reduced 47.57%
Applied Optoelectronics Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 26.91%
$9.12B
$1.81 Million
0.0% of portfolio
11,591
Q2 2025
Added 83.46%
$202M
$214,000
0.0% of portfolio
64,676
Q2 2025
Reduced 63.88%
$10.2B
$5.57 Million
0.0% of portfolio
133,056
Q2 2025
Reduced 40.15%
-
$0
0.0% of portfolio
-
Q4 2023
New
$510M
$125,000
0.0% of portfolio
40,700
Q2 2025
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 1.77%
$32.2B
$302,000
0.0% of portfolio
5,729
Q2 2025
New
Archimedes Tech Spac Partner
-
$0
0.0% of portfolio
-
Q2 2025
New
Archimedes Tech Spac Partner
-
$0
0.0% of portfolio
-
Q2 2025
New